Robinhood Telehealth family of companies
BPC-157 + TB-500 · 60-day protocol
Each bottle contains 20 mg total (10 mg BPC-157 + 10 mg TB-500). Two bottles provide 40 mg; the 60-day loading and maintenance schedule below uses the full 40 mg.
Subcutaneous abdomen reference: stay at least 2 inches from the belly button, rotate sites, and follow clinician instruction.
The displayed math uses daily injections. Some prescribers may elect Saturdays and Sundays off; that changes duration and unused quantity.
Reference schedule: 60 days total; any off period is determined by the prescriber.
Refrigerate. Use within 60 days only when the dispensing pharmacy's label permits it.
BPC-157 and TB-500 are experimental and are not FDA-approved drugs. FDA reports limited human safety data and potential concerns including immunogenicity, impurities, aggregation, and product-quality variability. Compounded drugs are not reviewed by FDA for safety, effectiveness, or quality before marketing. Do not self-prescribe or change a prescribed dose. Competitive athletes: both substances are prohibited by WADA.
Educational reference only. Final dose, route, sterility, storage, and beyond-use date must come from the prescriber and dispensing pharmacy. Verify vial label and syringe type before every injection.